Takeda spins norovirus vaccine out into separate companyTakeda has decided development of its norovirus vaccine candidate outside Japan will be more efficient if it is Share XTakeda spins norovirus vaccine out into separate companyhttps://pharmaphorum.com/news/takeda-spins-norovirus-vaccine-out-into-separate-company/
Biogen adds real-world test for Aduhelm to its confirmatory trialBiogen and partner Eisai have said they will run a large-scale observational study of Alzheimer’s drug Aduhelm in Share XBiogen adds real-world test for Aduhelm to its confirmatory trialhttps://pharmaphorum.com/news/biogen-adds-real-world-test-for-aduhelm-to-its-confirmatory-trial/
Amwell dials in deals worth $320m to buy two digital health playersUS telehealth group Amwell has agreed to buy two digital health specialists – SilverCloud Health and Conversa Health Share XAmwell dials in deals worth $320m to buy two digital health playershttps://pharmaphorum.com/news/amwell-dials-in-deals-worth-320m-to-buy-two-digital-health-players/
UK fines Advanz £100m for raising thyroid drug price tenfoldThe UK has levied another big fine for anticompetitive activity in the pharma market in a fortnight, with Share XUK fines Advanz £100m for raising thyroid drug price tenfoldhttps://pharmaphorum.com/news/uk-fines-advanz-100m-for-raising-thyroid-drug-price-tenfold/
FDA starts review of Roche’s eye disease drug, setting up 2022 verdictThe FDA has started a priority review of Roche’s bispecific antibody faricimab for two major causes of blindness, Share XFDA starts review of Roche’s eye disease drug, setting up 2022 verdicthttps://pharmaphorum.com/news/fda-starts-review-of-roches-eye-disease-drug-setting-up-2022-verdict/
AZ’s COVID-19 jab sales top $1.2bn, but come at a lossAstraZeneca said this morning that it has made $1.2 billion in sales from its COVID-19 vaccine Vaxzevria in Share XAZ’s COVID-19 jab sales top $1.2bn, but come at a losshttps://pharmaphorum.com/news/azs-covid-19-jab-sales-top-1-2bn-but-come-at-a-loss/
FDA clears Medtronic AI algorithms for cardiac monitoringTwo artificial intelligence (AI) algorithms designed to diagnose people with heart rhythm abnormalities have been approved by the Share XFDA clears Medtronic AI algorithms for cardiac monitoringhttps://pharmaphorum.com/news/fda-clears-medtronic-ai-algorithms-for-cardiac-monitoring/
FDA okays Viatris’ insulin drug as first ‘interchangeable’ biosimilarGeneric drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is Share XFDA okays Viatris’ insulin drug as first ‘interchangeable’ biosimilarhttps://pharmaphorum.com/news/fda-okays-mylan-insulin-drug-as-first-interchangeable-biosimilar/
Pfizer hikes COVID vaccine sales forecast for 2021 to $33.5bnContinuing orders for Pfizer’s BioNTech-partnered COVID-19 vaccine Comirnaty have prompted near one-third increase in its projected revenues for Share XPfizer hikes COVID vaccine sales forecast for 2021 to $33.5bnhttps://pharmaphorum.com/news/pfizer-hikes-covid-vaccine-sales-forecast-for-2021-to-33-5bn/
